Skip to main content
OpenTrials

Clinical trial condition

Adenocarcinoma

Explore clinical trials studying Adenocarcinoma. Study availability and eligibility vary by location and protocol.

5,027 public trials 1,169 recruiting studies
Refine in advanced search Browse all conditions

Adenocarcinoma trial results

Active, Not Recruiting

A Study of Selpercatinib (LY3527723) in Participants With RET-Mutant Medullary Thyroid Cancer

NCT04211337

Conditions
Adenocarcinoma, Carcinoma, Carcinoma, Medullary, +10 more
Locations
  • University of Alabama at Birmingham Birmingham, Alabama, United States
  • City of Hope National Medical Center Duarte, California, United States
  • UCLA Hematology/Oncology - Westwood (Building 100) Los Angeles, California, United States
  • University of California Davis (UC Davis) Comprehensive Cancer Center Sacramento, California, United States
View all 143 locations
View Trial Details
Active, Not Recruiting

Evaluation of Sentinel Node Policy in Early Stage Endometrial Carcinomas at Intermediate and High Risk of Recurrence.

NCT02598219

Conditions
Adenocarcinoma, Adnexal Diseases, Carcinoma, +20 more
Locations
  • Polyclinique Urbain V Avignon, France
  • Centre Hospitalier Régional Universitaire Besançon, France
  • Institut Bergonié Bordeaux, France
  • Centre Jean Perrin Clermont-Ferrand, France
View all 16 locations
View Trial Details
Active, Not Recruiting

Hypofractionated Radiation Therapy or Standard Radiation Therapy in Treating Patients With Ductal Breast Carcinoma In Situ or Early Invasive Breast Cancer

NCT01266642

Conditions
Adenocarcinoma, Breast Carcinoma In Situ, Breast Diseases, +19 more
Locations
  • Banner MD Anderson Cancer Center Gilbert, Arizona, United States
  • UF Cancer Center at Orlando Health Orlando, Florida, United States
  • MD Anderson in The Woodlands Conroe, Texas, United States
  • M D Anderson Cancer Center Houston, Texas, United States
View Trial Details
Active, Not Recruiting

Phase I Trial of Defactinib and VS-6766.

NCT03875820

Conditions
Adenocarcinoma, Adnexal Diseases, Carcinoma, +27 more
Locations
  • The Christie NHS Foundation Trust Manchester, Greater Manchester, United Kingdom
  • The Royal Marsden NHS Foundation Trust Sutton, Surrey, United Kingdom
  • The Royal Marsden NHS Foundation Trust - Gynecology Unit London, United Kingdom
  • The Newcastle Upon Tyne Hospitals NHS Foundation Trust - Freeman Hospital Newcastle, United Kingdom
View Trial Details
Active, Not Recruiting

A Study to Investigate the Efficacy and Safety of Volrustomig ± Casdatifan vs Nivolumab + Ipilimumab as 1L Treatment for Advanced ccRCC

NCT07000149

Conditions
Adenocarcinoma, Advanced Clear Cell Renal Cell Carcinoma, Carcinoma, +15 more
Locations
  • Research Site La Jolla, California, United States
  • Research Site Aurora, Colorado, United States
  • Research Site Boston, Massachusetts, United States
  • Research Site New York, United States
View all 32 locations
View Trial Details

Related conditions